Scientech Research LLC’s MetLife MET Stock Holding History

Scientech Research LLC’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,763	Closed	-$264K	–	753
2024 Q2	$264K	Buy	+3,763	New	+$269K	0.05%	478

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Scientech Research LLC's MET Position: Q3 2024 in Review

Scientech Research LLC sold out of MetLife (MET) in Q3 2024, closing a stake of 3,763 shares — an estimated $264K sold.

Scientech Research LLC first reported a position in MET in Q2 2024 and held it in 1 quarter. The position peaked at $264K in Q2 2024. 1,315 funds tracked by Wall St. Rank hold MET as of Q3 2024.

Scientech Research LLC reported no remaining MetLife position as of Q3 2024 after selling out during the quarter.
Scientech Research LLC sold 3,763 MetLife shares in Q3 2024, an estimated $264K.
Scientech Research LLC first reported a position in MetLife in Q2 2024 and held it in 1 quarter.
Scientech Research LLC's MetLife position peaked at $264K in Q2 2024.
1,315 funds tracked by Wall St. Rank held MetLife as of Q3 2024.

Based on Scientech Research LLC's 13F filing for Q3 2024, filed 14 Nov 2024.